ESPN’s Dick Vitale, 86, faces his fifth cancer as melanoma spreads to the lung and liver. He remains optimistic, highlighting ...

Spending time outdoors can reduce stress and improve well-being, possibly lowering inflammation, when you have RA. These tips ...

Immune-mediated inflammatory diseases appear to be linked to increased risk for cancer across various subtypes.

Morning joint stiffness easing with movement may signal Rheumatoid Arthritis, not routine strain. Early diagnosis and ...

Trial met all primary and key secondary endpoints, including progression-free survival and overall survival Company intends to include these data ...

In a preclinical study published today in Cancer Research, a journal of the American Association for Cancer Research, ...

The iconic four-block takeover returns April 24 with dishes from more than 50 restaurants, more than 200 global sips, next-level entertainment, and Southern Glazer’s Wine & Spirits as exclusive ...

AstraZeneca AZN-1.65%decrease; red down pointing triangle said a lung-disease drug candidate met the primary goal in two late-stage clinical trials, reducing the rate at which patients’ symptoms ...

AstraZeneca shares rose after the company said a drug candidate met the primary goal in two late-stage trials for a deadly lung disease, clearing the path to seek approval from regulators. The U.K.

NEW YORK, Feb. 24, 2026 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) announces a new research collaboration with AstraZeneca aimed at driving progress in small cell lung cancer (SCLC) ...

AstraZeneca said its experimental drug ceralasertib in combination with approved cancer treatment Imfinzi didn’t meet the primary goal of a late-stage clinical trial for advanced lung cancer. The U.K.